Luina Bio and Griffith University Position to Develop Coronavirus Vaccine
13 March 2020 Luina Bio is delighted to announce they have entered into a MoU with Griffith University targeting the development of a Coronavirus vaccine. With COVID-19 now declared as a pandemic and world financial markets stumbling, the…
New drug discovery centre to fast-track medicines
12 March 2020 A state-of-the-art facility to fast-track new medicines for Australian patients will today be opened by Australian Minister for Health the Hon. Greg Hunt MP and Victorian Minister for Health the Hon. Jenny Mikakos MP at…
Innovative mobile hepatitis C clinic receives funding as Australia drives towards elimination of the disease by 2030
12 March 2020 Melbourne – Gilead Sciences ANZ has today announced the winners of its 2020 Gilead Fellowship Research Grants Program, with the seven recipient projects focused on improving patient outcomes in HIV, liver diseases, invasive fungal infections,…
Coronavirus – What you need to know if you are working from home
11 March 2020 It seems that we can’t catch a break! This time it’s not a computer virus, but rather a real virus. The outcome, however, is very similar – disruption to your business. Businesses are mitigating these…
Novel compound sparks new malaria treatment hope
5 March 2020 A novel class of antimalarial compounds that can effectively kill malaria parasites has been developed by Australian and US researchers. (L-R) Dr Manuel de la Ruiz, Professor Alan Cowman, Dr David Olsen and Dr Paola…
Trajan and Queen’s University awarded Mitacs grant to develop MES technology for mass spectrometry
2 March 2020 Kingston, Ontario, Canada Trajan Scientific and Medical (Trajan) and Queen’s University (Queen’s), Kingston, Canada, have been awarded a Mitacs Accelerate grant to develop new multiple electrospray (MES) technologies to increase throughput and sensitivity in mass…
Doherty Institute awarded AU$3.2 million by the Jack Ma Foundation to accelerate a vaccine for COVID-19
3 March 2020 The Peter Doherty Institute for Infection and Immunity (Doherty Institute) – a joint venture between the University of Melbourne and The Royal Melbourne Hospital – has been awarded AU$3.2 million (US$2.15 million) by the Jack…
OMX Solutions Pty Ltd custom-made medical device, the OMX Craniofacial Fixation Plate, gains inclusion on the Australian Register of Therapeutic Goods
25 February 2020 OMX Solutions Pty Ltd is pleased to announce the Australian regulatory approval of its latest custom-made medical device (CMMDs), the OMX Craniofacial Fixation Plate Kit. A CMMD is a one-off medical device prescribed for the…
Funding boost welcomed for hepatitis C rapid diagnostic: Burnet Institute
18 February, 2020 A Burnet project developing a rapid diagnostic test for hepatitis C received a major boost after being awarded funding through the Victorian Medical Research Acceleration Fund (VMRAF). The project, which will speed up access to…
New front opened in fight against common cancer driver
20 February 2020 Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are driven by one of the most common cancer-causing changes in cells. A new vulnerability in lymphomas driven by MYC has…
How the brain’s immune system could be harnessed to improve memory
11 February 2020 Story: Gosia Kaszubska, for RMIT When it comes to memory, immune cells are known as the “bad cops” of the brain. But new research shows they could also be turned into “good cops” to power memory…
Humanitarian Award to support HMHB: Burnet Institute
19 February, 2020 Image: Mark Sullivan (left) with Burnet Institute Director and CEO, Professor Brendan Crabb AC Two pioneering Australians, acknowledged for their contribution to end the debilitating disease river blindness, have generously dedicated the prize money from…
